Page 9 - Recursion Pharmaceuticals News Today

Britain is not alone in the doldrums. The economic climate from East to West is equally stormy, with Japan in recession and China struggling.

Do you want to invest like Nvidia? Here are the stocks to buy if you want to follow the chipmaker's methodology and focus on AI exposure.

A top name in the artificial intelligence world has put its money where its mouth is with this biotech.

Nvidia Stock Target: The rally showed Nvidias growing influence in the AI world as its market value grows at a scorching pace, making it the third most-valuable U.S. company. Its largest investment of $147.3 million was in Arm Holdings, the chip designer that Nvidia failed to buy after the $80 billion deal hit the antitrust hurdle two years ago.

Shares of biotech firm Recursion Pharmaceuticals, in which Nvidia invested nearly $76 million, gained 5%. Last year, Nvidia had said it would invest in it to speed up training of the Utah-based firms AI models for drug discovery.

Finding an up-and-coming stock worth investing in is harder than it used to be, but you don't have to look far if you check out this list.

Recursion Pharmaceuticals (RXRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Baillie Gifford & Co. lowered its holdings in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 2.2% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 24,551,409 shares of the company’s stock after selling 546,221 shares during the quarter. Baillie Gifford & […]

Baillie Gifford & Co. lowered its stake in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 2.2% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 24,551,409 shares of the company’s stock after selling 546,221 shares during the period. Baillie Gifford & Co. owned approximately 11.39% […]

Wall Street's favorite chip maker disclosed stakes in a handful of AI and other companies this week — and promptly sent shares rising